Literature DB >> 16174877

"The death rattle" in the intensive care unit after withdrawal of mechanical ventilation in neurological patients.

Erwin J O Kompanje1.   

Abstract

The noise produced by oscillatory movements of secretions in the oropharynx, hypopharynx, and trachea during inspiration and expiration in unconscious terminal patients is often described as "the death rattle." The secretions are produced by the salivary glands and bronchial mucosa. These patients are usually too weak to expectorate or swallow the migrating secretions. Sputum usually only accumulates in these areas if there is a significant impairment of the cough reflex, as in deep coma or near death. Reported incidence of death rattle in terminal patients varied between 6 and 92%. Death rattle was most commonly reported in patients dying from pulmonary malignancies, primary brain tumors, or brain metastases, and predicts death within 48 hours in 75% of the patients. After withdrawal of artificial ventilation from the intensive care unit, excessive respiratory secretion resulting in a rattling breathing during the last hours of life is not uncommon, especially not in pulmonary and neurological patients. The distressing experience and negative influence in the bereavement process indicates an ethical demand to treat this symptom from the perspective of others merely than that of the patient.

Entities:  

Mesh:

Year:  2005        PMID: 16174877     DOI: 10.1385/NCC:3:2:107

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  17 in total

1.  Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care.

Authors:  Mike Bennett; Viv Lucas; Mary Brennan; Andrew Hughes; Valerie O'Donnell; Bee Wee
Journal:  Palliat Med       Date:  2002-09       Impact factor: 4.762

2.  Contributing factors to physical symptoms in terminally-ill cancer patients.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  J Pain Symptom Manage       Date:  1999-11       Impact factor: 3.612

3.  Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  Palliat Med       Date:  2000-01       Impact factor: 4.762

4.  Factors considered important at the end of life by patients, family, physicians, and other care providers.

Authors:  K E Steinhauser; N A Christakis; E C Clipp; M McNeilly; L McIntyre; J A Tulsky
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

5.  The last 48 hours of life.

Authors:  I Lichter; E Hunt
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

6.  Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity.

Authors:  F Pochard; E Azoulay; S Chevret; F Lemaire; P Hubert; P Canoui; M Grassin; R Zittoun; J R le Gall; J F Dhainaut; B Schlemmer
Journal:  Crit Care Med       Date:  2001-10       Impact factor: 7.598

Review 7.  Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003.

Authors:  Jean Carlet; Lambertus G Thijs; Massimo Antonelli; Joan Cassell; Peter Cox; Nicholas Hill; Charles Hinds; Jorge Manuel Pimentel; Konrad Reinhart; Boyd Taylor Thompson
Journal:  Intensive Care Med       Date:  2004-04-20       Impact factor: 17.440

8.  A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.

Authors:  I N Back; K Jenkins; A Blower; J Beckhelling
Journal:  Palliat Med       Date:  2001-07       Impact factor: 4.762

9.  Respiratory tract secretions in the dying patient: a retrospective study.

Authors:  Robin Martin Kåss; John Ellershaw
Journal:  J Pain Symptom Manage       Date:  2003-10       Impact factor: 3.612

10.  Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study.

Authors:  Tatsuya Morita; Ichinosuke Hyodo; Taisuke Yoshimi; Masayuki Ikenaga; Yoichiro Tamura; Akitaka Yoshizawa; Akira Shimada; Tatsuo Akechi; Isamu Adachi
Journal:  J Pain Symptom Manage       Date:  2004-06       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.